Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging
癌症和衰老中内分泌和心脏代谢异常的指导
基本信息
- 批准号:10300180
- 负责人:
- 金额:$ 18.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAgingAmericanAndrogensAreaAwardBaltimoreBenefits and RisksBostonCancer BurdenCapsicumCardiometabolic DiseaseCaringClinicalClinical ResearchClinical TrialsColorectal CancerDataDepositionDeteriorationDiabetes MellitusDiagnosisDiseaseEndocrineEndocrine System DiseasesEndocrinologistEndocrinologyEnrollmentEnvironmentErythropoiesisFacultyFatigueFatty LiverFatty acid glycerol estersFosteringFunctional disorderFundingGeneral PopulationGeriatricsGoalsGrantHealthHigh PrevalenceHospitalsHypogonadismIncidenceInfiltrationInflammationInfrastructureInstitutionInsulin ResistanceInternationalInvestigationK-Series Research Career ProgramsLeadLongitudinal StudiesLower ExtremityMagnetic Resonance SpectroscopyMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMeasuresMedicalMedicineMentorsMentorshipMetabolicMetabolic syndromeMetabolismMetastatic Prostate CancerMid-Career Clinical Scientist Award (K24)Morbidity - disease rateMuscleOncologyParticipantPhysical FunctionPhysical PerformanceProstateResearchResearch InstituteResearch PersonnelResearch SupportResourcesRoleScienceSeriesSkeletal MuscleTestosteroneThinnessTimeTissuesTrainingTranslational ResearchUnited StatesUnited States National Institutes of HealthUpper ExtremityUrologyWomanWorkage relatedandrogen deprivation therapycardiometabolic riskcardiometabolismcareerclinical centerclinical investigationcytokinedisabling symptomfrailtyimprovedinterestmedical schoolsmedical specialtiesmenmid-career facultymultidisciplinarymuscle formmuscle strengthnext generationnovelolder menpatient oriented researchprogramsprospectiveprostate cancer survivorsreduced muscle strengthside effectskills
项目摘要
PROJECT SUMMARY
Shehzad Basaria, MD, an Associate Professor of Medicine and Endocrinology in the Division of Endocrinology,
Diabetes, & Metabolism at Brigham and Women's Hospital, Harvard Medical School, submits this application
for a K24 Mid-Career Development award to provide protected time to mentor trainees in Patient-Oriented
Research (POR) in Endocrine aspects of Gero-Oncology. Dr. Basaria is one of the few endocrinologists
worldwide specializing in endocrine and cardio-metabolic disorders in older men with cancer and androgen
deficiency. He will pursue additional training to hone his mentoring skills in order to build on his established
record of mentorship and foster the research careers of early investigators.
Candidate: Dr. Basaria is a highly productive clinical researcher in the field of Endocrinology, Aging and
Cancer. Since 2003, he has been continuously NIH-funded to investigate: i) endocrine and cardio-metabolic
complications of androgen deprivation therapy (ADT) in men with prostate cancer (PCa), ii) benefits and risks
of androgen replacement in older men, and iii) endocrinology of aging. He has conducted his investigations
using NIH-supported infrastructure, including RO1s and R21 grants, data from the Baltimore Longitudinal
Study of Aging (BLSA), the InChianti Study, and the Boston Pepper Center for Function-Promoting Therapies.
With his uncommon skill set and strong POR program in Endocrinology and Gero-Oncology, he has been a
sought-after collaborator and mentor at Brigham/Harvard and at national and international institutions.
Mentoring Plan/Environment: This application will leverage the extensive training resources at
Brigham/Harvard, including the Center for Clinical Investigation, the Brigham Research Institute for Clinical and
Translational Research, and T32 training grants in a variety of specialties. It will also draw on the unparalleled
resources of the Boston Pepper Center and other funded studies to serve as a platform for POR trainees at
multiple levels.
Research Plan: The novel research supported by this K24 award will make significant contributions to the
1A) The
impact of ADT-induced profound hypogonadism and the resulting decline in muscle mass on physical function,
1B) The impact of ADT on fat infiltration of skeletal muscles and the association of this deterioration in muscle
quality on physical function, and 2) The mechanisms by which testosterone replacement improves Cancer-
Related Fatigue in older men with cancer.
understanding of the impact of androgen deficiency in older men with cancer in three major areas:
These novel aims will build on the ongoing work in Dr. Basaria's
current R01s, explore new hypotheses, and expand opportunities for trainees.
项目概要
Shehzad Basaria 医学博士,内分泌科医学和内分泌学副教授,
哈佛医学院布莱根妇女医院的糖尿病和新陈代谢提交了此申请
获得 K24 职业中期发展奖,为以患者为导向的学员提供受保护的时间指导
老年肿瘤学内分泌方面的研究(POR)。 Basaria 博士是少数内分泌学家之一
全球范围内专门研究患有癌症和雄激素的老年男性的内分泌和心脏代谢疾病
不足。他将接受额外的培训来磨练他的指导技能,以便在他既定的基础上再接再厉。
指导记录并促进早期研究人员的研究生涯。
候选人:Basaria 博士是内分泌学、衰老学和内分泌学领域一位高产的临床研究员。
癌症。自 2003 年以来,他持续获得 NIH 资助,研究:i) 内分泌和心脏代谢
前列腺癌 (PCa) 男性雄激素剥夺疗法 (ADT) 的并发症,ii) 益处和风险
老年男性雄激素替代的研究,以及 iii) 衰老内分泌学。他已经进行了调查
使用 NIH 支持的基础设施,包括 RO1 和 R21 拨款、来自巴尔的摩纵向的数据
衰老研究 (BLSA)、InChianti 研究和波士顿胡椒功能促进治疗中心。
凭借他在内分泌学和老年肿瘤学方面非凡的技能和强大的 POR 计划,他一直是
在布里格姆/哈佛大学以及国家和国际机构中广受欢迎的合作者和导师。
指导计划/环境:此应用程序将利用以下位置的广泛培训资源:
布里格姆/哈佛大学,包括临床研究中心、布里格姆临床和临床研究所
各种专业的转化研究和 T32 培训补助金。它还将借鉴无与伦比的
波士顿胡椒中心的资源和其他资助的研究为 POR 学员提供了一个平台
多个级别。
研究计划:本次K24奖支持的新颖研究将为该领域做出重大贡献
1A)
ADT 引起的严重性腺功能减退症以及由此导致的肌肉质量下降对身体功能的影响,
1B) ADT 对骨骼肌脂肪浸润的影响以及这种肌肉退化的关联
身体机能质量,以及 2) 睾酮替代疗法改善癌症的机制-
患有癌症的老年男性的相关疲劳。
了解雄激素缺乏对患有癌症的老年男性在三个主要方面的影响:
这些新颖的目标将建立在 Basaria 博士正在进行的工作的基础上
现有的 R01,探索新的假设,并为学员扩大机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shehzad Basaria其他文献
Shehzad Basaria的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shehzad Basaria', 18)}}的其他基金
Exploring the Role of Testosterone as a Novel Anti-Nociceptive Agent in Women with Chronic Pain and Opioid Use
探索睾酮作为新型抗伤害剂对患有慢性疼痛和阿片类药物使用的女性的作用
- 批准号:
10413965 - 财政年份:2021
- 资助金额:
$ 18.48万 - 项目类别:
Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging
癌症和衰老中内分泌和心脏代谢异常的指导
- 批准号:
10469444 - 财政年份:2021
- 资助金额:
$ 18.48万 - 项目类别:
Exploring the Role of Testosterone as a Novel Anti-Nociceptive Agent in Women with Chronic Pain and Opioid Use
探索睾酮作为新型抗伤害剂对患有慢性疼痛和阿片类药物使用的女性的作用
- 批准号:
10189910 - 财政年份:2021
- 资助金额:
$ 18.48万 - 项目类别:
Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging
癌症和衰老中内分泌和心脏代谢异常的指导
- 批准号:
10652585 - 财政年份:2021
- 资助金额:
$ 18.48万 - 项目类别:
Androgen Replacement to Improve Patient-Important Outcomes in Men with Opioid-Induced Hypogonadism
雄激素替代疗法可改善阿片类药物引起的性腺功能减退症男性患者的重要预后
- 批准号:
10426373 - 财政年份:2020
- 资助金额:
$ 18.48万 - 项目类别:
Androgen Replacement to Improve Patient-Important Outcomes in Men with Opioid-Induced Hypogonadism
雄激素替代疗法可改善阿片类药物引起的性腺功能减退症男性患者的重要预后
- 批准号:
10118343 - 财政年份:2020
- 资助金额:
$ 18.48万 - 项目类别:
Androgen Replacement to Improve Patient-Important Outcomes in Men with Opioid-Induced Hypogonadism
雄激素替代疗法可改善阿片类药物引起的性腺功能减退症男性患者的重要预后
- 批准号:
10266840 - 财政年份:2020
- 资助金额:
$ 18.48万 - 项目类别:
Preventing a Decline in Physical Function in Older Androgen-Deprived Men with Structured Exercise Training
通过结构化运动训练预防雄激素缺乏的老年男性身体机能下降
- 批准号:
10090555 - 财政年份:2020
- 资助金额:
$ 18.48万 - 项目类别:
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer
通过睾酮替代疗法改善有癌症病史的性腺功能减退男性的患者重要结果
- 批准号:
9927605 - 财政年份:2019
- 资助金额:
$ 18.48万 - 项目类别:
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency
改善患有癌症和雄激素缺乏的老年男性与癌症相关的疲劳、性功能障碍和生活质量
- 批准号:
10212212 - 财政年份:2019
- 资助金额:
$ 18.48万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
A2E老化ARMS2/HTRA1型iPSC-RPE细胞的研究:个体化AMD发病机制初步探索
- 批准号:81400412
- 批准年份:2014
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 18.48万 - 项目类别:
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)
停止使用羟氯喹治疗老年狼疮病 (SHIELD)
- 批准号:
10594743 - 财政年份:2023
- 资助金额:
$ 18.48万 - 项目类别:
Chronic Pain and Risk of Alzheimer's-Related Neurodegeneration
慢性疼痛和阿尔茨海默病相关神经变性的风险
- 批准号:
10644253 - 财政年份:2023
- 资助金额:
$ 18.48万 - 项目类别:
The contribution of air pollution to racial and ethnic disparities in Alzheimer’s disease and related dementias: An application of causal inference methods
空气污染对阿尔茨海默病和相关痴呆症的种族和民族差异的影响:因果推理方法的应用
- 批准号:
10642607 - 财政年份:2023
- 资助金额:
$ 18.48万 - 项目类别:
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
镰状细胞病的克隆造血和遗传变异
- 批准号:
10638404 - 财政年份:2023
- 资助金额:
$ 18.48万 - 项目类别: